In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune Response

© 2021 Wiley-VCH GmbH.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 31 vom: 28. Aug., Seite e2100628
Auteur principal: Ngamcherdtrakul, Worapol (Auteur)
Autres auteurs: Reda, Moataz, Nelson, Molly A, Wang, Ruijie, Zaidan, Husam Y, Bejan, Daniel S, Hoang, Ngoc Ha, Lane, Ryan S, Luoh, Shiuh-Wen, Leachman, Sancy A, Mills, Gordon B, Gray, Joe W, Lund, Amanda W, Yantasee, Wassana
Format: Article en ligne
Langue:English
Publié: 2021
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article cancer immunotherapy intratumoral therapy melanoma nanotechnology translational research STAT3 Transcription Factor RNA, Small Interfering Cancer Vaccines